Literature DB >> 12548253

Trends in antibiotic use and cost and influence of case-mix and infection rate on antibiotic-prescribing in a long-term care facility.

Joseph M Mylotte1, Melva Neff.   

Abstract

BACKGROUND: Antibiotic use and cost indicators have been developed specifically for the long-term care facility (LTCF) setting. Approximately 50% of the variation in these indicators was explained by the variation in infection rate. The objectives of this study were to further assess the utility of the antibiotic use and cost indicators in a different LTCF and to determine the correlation of case-mix and these indicators.
METHODS: Antibiotic use and cost indicators were collected monthly by unit (N = 10) and by physician (N = 6) at a 433-bed LTCF in Syracuse, New York, from February 1999 to September 2001. Indicators included incidence (number of antibiotic courses per 1000 resident care-days) of antibiotic use, antibiotic utilization ratio ([AUR]; ratio of the number of antibiotic-days to the number of resident care-days), cost per antibiotic-day, and cost per resident care-day. Case-mix variation was measured with the case-mix index (CMI) of the Resource Utilization Group II system. Simple linear and multilinear regression analyses were used to evaluate correlations of continuous variables.
RESULTS: Among the 10 units or 6 physicians, there was a significant difference in the average values for all indicators. Correlation between unit- or physician-specific CMI and antibiotic use or cost indicators or infection rate was poor. However, there was a significant positive correlation between unit- or physician-specific infection rate and incidence of antibiotic use, AUR, and cost per resident care-day but not cost per antibiotic-day. With use of multilinear regression analysis to control for CMI and cost per antibiotic-day, infection rate was a significant predictor of incidence of antibiotic use (R2 = 0.65; P <.001) and AUR (R2 = 0.78; P <.001).
CONCLUSIONS: This study provides further evidence that the antibiotic use and cost indicators developed specifically for LTCFs can detect significant variation among units within a facility and among physicians. However, there was no correlation between CMI and antibiotic use or cost indicators. After controlling for case-mix variation and cost per antibiotic-day, variation in infection rate explained most of the variation in incidence of antibiotic use and AUR.

Mesh:

Substances:

Year:  2003        PMID: 12548253     DOI: 10.1067/mic.2003.47

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  5 in total

1.  Predictors of potentially suboptimal treatment of urinary tract infections in long-term care facilities.

Authors:  H J Appaneal; A R Caffrey; V V Lopes; V Mor; D M Dosa; K L LaPlante; T I Shireman
Journal:  J Hosp Infect       Date:  2021-02-05       Impact factor: 3.926

2.  Benefits of WSES guidelines application for the management of intra-abdominal infections.

Authors:  Belinda De Simone; Federico Coccolini; Fausto Catena; Massimo Sartelli; Salomone Di Saverio; Rodolfo Catena; Antonio Tarasconi; Luca Ansaloni
Journal:  World J Emerg Surg       Date:  2015-03-18       Impact factor: 5.469

3.  Development of a core outcome set for clinical trials aimed at improving antimicrobial stewardship in care homes.

Authors:  Hoa Q Nguyen; Declan T Bradley; Michael M Tunney; Carmel M Hughes
Journal:  Antimicrob Resist Infect Control       Date:  2021-03-09       Impact factor: 4.887

4.  Asymptomatic bacteriuria, antibiotic use, and suspected urinary tract infections in four nursing homes.

Authors:  Charles D Phillips; Omolola Adepoju; Nimalie Stone; Darcy K McMaughan Moudouni; Obioma Nwaiwu; Hongwei Zhao; Elizabeth Frentzel; David Mehr; Steven Garfinkel
Journal:  BMC Geriatr       Date:  2012-11-23       Impact factor: 3.921

5.  Performance evaluation of inpatient service in Beijing: a horizontal comparison with risk adjustment based on Diagnosis Related Groups.

Authors:  Weiyan Jian; Yinmin Huang; Mu Hu; Xiumei Zhang
Journal:  BMC Health Serv Res       Date:  2009-04-30       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.